Cardiovascular Needle Market Size, Share & Trends Analysis Report By Product Type (Round Bodied Needles And Cutting Needles), By Usage (Single Use Or Eyeless Needles And Multiple Use Or Eyed Needles), And Segment Forecasts, 2019 To 2025

The global cardiovascular needles market is driven by an increase in demand for cardiovascular needles due to the rising number of cardiovascular interventions across the globe. Cardiovascular needles are used during a number of cardiovascular surgeries such as open-heart surgery, cardiac valve procedures, heart transplant, etc. The factors that propel the growth of the global cardiovascular needle market include the rising geriatric population and the rising occurrence of cardiovascular diseases. There are also other factors that fuel the growth of the market such as excessive intake of tobacco, high smoking population, obesity, increasing co-morbidities, and changing standard of living. 

On the other hand, there are also factors that hamper the growth of the market such as increasing usage of surgical staples rather than needles. The global cardiovascular needle market is classified on the basis of product type, usage, applications, end-use, and geography. On the basis of product type, the global market is classified into two major types: round-bodied needles and cutting needles. Round bodied needles consist of taper point needles and blunt point needles. The cutting needles consist of conventional cutting needles and reverse cutting needles.

On the basis of usage, the global cardiovascular needle market is classified into single-use or eyeless needles and multiple-use or eyed needles. Among the usage, the single-use needles segment is projected to have a greater share owing to the growing number of outpatient procedures as well as growing awareness about infectious diseases. On the basis of applications, the global market is classified as open-heart surgery, cardiac valve procedures, coronary artery bypass graft surgery, heart transplant, and others.

On the basis of end-user, the global cardiovascular needle market is classified as hospitals and ambulatory surgical centers. Among the end-user, the hospital segment is estimated to account for a major share owing to the rising number of persistent cardiovascular interventions. On the basis of geography, the global market is classified as North America, Latin America, Eastern Europe, Western Europe, and Asia Pacific excluding Japan, Japan, and Middle East & Africa.

The North American region comprises the U.S. and Canada. Latin America comprises Mexico and Brazil. The Western European region comprises Germany, Italy, France, England, Spain, Nordic countries, and BENELUX. The Eastern European region comprises Poland, Russia, and the Rest of Eastern Europe. Asia Pacific region comprises China, India, ASEAN, and Australia & New Zealand. The Middle East and Africa region comprises GCC, South Africa, North Africa, and the Rest of MEA.

In the case of geographical region, the North American region dominates a major share of the global cardiovascular needle market over the forecast due to the increasing geriatric population, advanced healthcare facilities, and increased life expectancy. Moreover, the introduction of the latest technology such as laser-drilled cardiovascular needles is projected to fuel the demand for the market over the forecast period.

The North American market is followed by Europe as well as Asia Pacific. Europe and Asia Pacific equally hold the second-largest position in the global cardiovascular needle market. Some of the prominent players that fuel the growth of the global market include Barber of Sheffield Ltd., CP Medical, Inc., Ethicon US, LLC, MANI, Inc., FSSB surgical needles GmbH SMB Corporation, Quality Needles Pvt. Ltd., etc.